Search Browse Earnings

Celldex Therapeutics, Inc. — SlamSEC

Celldex Therapeutics, Inc.

Nasdaq:CLDX

In Vitro & In Vivo Diagnostic Substances·HAMPTON, NJ

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$6.9M

+192.0% YoY

FY 2025

Adj. EBITDA

-$151.5M

-2201.6% margin

FY 2025

Net Income

-$141.4M

-2054.8% margin

FY 2025

EPS (Diluted)

-$2.92

FY 2025

Stock Price

$29.51

-1.2%

2026-03-13

52W Range

$14.40 – $31.99

P/E Ratio

-10.1x

Market Cap

$2.0B

Cash

$28.4M

FY 2025

Total Debt

—

Net Cash

$28.4M

FY 2025

Enterprise Value

$1.9B

Debt / EBITDA

0.2x

FY 2025

EV / EBITDA

-12.8x

Employees

—